IRCT20191014045103N1 IRCT 2019-11-23 Arak University of Medical Sciences Effect of Tranexamic acid on mortality and morbidity in spontaneously ICH patients Effect of Tranexamic acid on mortality and morbidity in spontaneously ICH patients 2019-12-06 anticipated 94 Complete https://irct.ir/trial/43431 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: This study is a randomized double-blind clinical trial study on 94 patients undergoing tranexamic acid injections who will divided into two equal groups using placebo and tranexamic acid by blocking randomization method, Blinding description: In this study only the expert in charge of the study is aware of the type of study and study groups while patients are not aware of the type of injectable drug. Also, the intern in charge of the plan, which is responsible for filling in the checklist, is not aware of the type of injectable drug group and only knows the groups based on A and B and fills out the checklists accordingly. 3 Intracerebral hemorrhage. Intervention 1: Intervention group: 47 patients with spontaneous ICH receive tranexamic acid, 1 g bolus in the first 10 minutes and 1 g intravenous infusion in the first 8 hours. Patients are then assessed on the basis of a checklist including the number of days of hospitalization and clinical status based on the NHISS form. Intervention 2: Control group: 47 patients with spontaneous ICH receive normal saline as 1 gram bolus in the first 10 minutes and 1 gram intravenous infusion in the first 8 hours. Hospitalization and clinical status are assessed on the basis of the NHISS form. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is I haven't decided yet